about
Bone turnover markers in primary hyperparathyroidism.Association between nutritional status and Modic classification in degenerative disc disease.Nmp4/CIZ: road block at the intersection of PTH and load."Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density".The effect of metyrosine/prednisolone combination to oophorectomy-induced osteoporosis.Intracortical remodeling parameters are associated with measures of bone robustness.Vitamin D levels appear to be normal in Danish patients attending secondary care for low back pain and a weak positive correlation between serum level Vitamin D and Modic changes was demonstrated: a cross-sectional cohort study of consecutive patienEffect of parathyroidectomy versus risedronate on volumetric bone mineral density and bone geometry at the tibia in postmenopausal women with primary hyperparathyroidism.The role of mast cells in parathyroid bone disease.Continuous elevation of PTH increases the number of osteoblasts via both osteoclast-dependent and -independent mechanisms.Post-surgical follow-up of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1.Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1.Bone disease in primary hyperparathyrodism.Fibroblast growth factor 23: state of the field and future directionsCorrelation of Vitamin D and Body Mass Index with Modic Changes in Patients with Non-Specific Low Back Pain in a Sub-Tropical Asian PopulationSex and age modify biochemical and skeletal manifestations of chronic hyperparathyroidism by altering target organ responses to Ca2+ and parathyroid hormone in mice.Normocalcemic primary hyperparathyroidism in a patient with severe osteoporosis receiving teriparatide.Patient-specific bone modelling and remodelling simulation of hypoparathyroidism based on human iliac crest biopsiesEffect of methylprednisolone on bone mineral density in rats with ovariectomy-induced bone loss and suppressed endogenous adrenaline levels by metyrosine.Increased bone mineral density in patients with non-alcoholic steatohepatitis.Primary hyperparathyroidism with rare presentation as multiple brown tumours.Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery?The pathogenesis, treatment and prevention of osteoporosis in men.Melatonin and the skeleton.The PTH-Vitamin D-FGF23 axis.Bilateral pathologic mid-tibial stress fractures: Initial presentation of mild primary hyperparathyroidism.Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism.Relationship between insulin sensitivity and bone mineral density in primary hyperparathyroidism.Interplay between serum osteocalcin and insulin sensitivity in primary hyperparathyroidism.BMD improvements after operation for primary hyperparathyroidism.Gender-Specific Differences in the Skeletal Response to Continuous PTH in Mice Lacking the IGF1 Receptor in Mature Osteoblasts.Catabolic Effects of Human PTH (1-34) on Bone: Requirement of Monocyte Chemoattractant Protein-1 in Murine Model of Hyperparathyroidism.Muscle function is impaired in patients with "asymptomatic" primary hyperparathyroidism.Long-term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women.Parathyroid-hormone variance is only marginally explained by a panel of determinants: a cross-sectional study of 909 hip-fracture patients.Over-expression of Adamts1 in mice alters bone mineral density.Capturing microscopic features of bone remodeling into a macroscopic model based on biological rationales of bone adaptation.Subclinical urolithiasis in patients with asymptomatic primary hyperparathyroidismAssociations between trabecular bone score and biochemistry in surgically vs conservatively treated outpatients with primary hyperparathyroidism: A retrospective cohort studySclerostin and DKK1 in Primary Hyperparathyroidism
P2860
Q27692682-973F7271-B9F6-4582-BE65-17F8A7BC5D2FQ31096990-57D3E7FD-6CEE-462B-8834-8E9D389E8ACDQ33636466-356E369D-4BD3-478C-86AB-E6A063143302Q34106682-9F2BEC87-48C3-4069-9AF1-FAEF32F10622Q34196596-83E8E960-A7E2-49DD-B30A-C55F9787B871Q34203425-AE8AB330-D1CC-4B48-AC72-0567646DC329Q34622520-D8C48782-2C1A-4104-B9EA-CBA318C6F1ABQ34734794-8FDF9838-8439-495D-8C7F-BA92074374C7Q35157842-37C2DC34-9771-460E-8570-9B343159F489Q35229844-5A23D7EC-BCE8-499E-A0AF-8BCD809D5D1EQ35895464-2443B578-0FCC-4F98-8F77-7D616CFCA59AQ35897668-3AE932BB-B92E-4F30-A702-2D5AD0651440Q36280845-B41D2144-7E09-4B1C-A760-B9814DC9E227Q36413230-949C3411-3F56-4137-9F5F-C1AFD20D608CQ36609921-D15F3430-A508-4341-8C49-7861CAD1E57AQ36741785-74FA818F-7744-4FF8-846F-A17CC29A24F5Q36930755-FF592F18-B72C-469C-8DB1-0D8F02B732B5Q36986456-9E46212D-341A-4000-A51E-B972587B67BCQ37133299-CE2E509A-88F7-4C4E-8C87-662E04E7DDDCQ37358283-832447A1-5AF0-4939-980A-C0F993AC3BA0Q37694223-6AA8DC3A-799C-4DD8-9449-7E32FBF33464Q38010033-E325D197-60DD-47B6-8760-68775E251FBAQ38074897-65FED535-1ED7-4FF0-B4D5-DCA1DF378F70Q38110221-5FA241AC-25A1-4270-9C45-F841559AF4A4Q38571195-65777ED5-5EEA-426F-9F3B-75153AD47F64Q41379281-53675134-8E62-483D-AC12-4EBA2118D55DQ43819872-20CBB5CF-8EB8-456B-942A-2A9DEE30440DQ44066537-8EEB24A7-5EE3-43DA-992F-19A1686CF7BDQ44090849-414C0122-108F-493D-A578-DAB3EAC5937CQ44217990-25319694-81CA-4F0D-B8EA-9D0EB3FE390EQ46693517-394C498C-F509-4424-9974-AC3AA9E70A7AQ46815320-BF3B841D-B506-4C83-AA9B-CF6A165A581CQ48156628-CA90D43A-F802-4C29-8882-C59344F5D74AQ48853983-1D7B3C60-B49B-476A-869D-C73B23B1F236Q51143829-D24A6304-E6DF-4A04-9401-9B09BD9BB6F1Q51401449-D3C872F9-7463-42D2-B55C-803EB1E38FB5Q53493481-BB5F558C-F777-4A63-8934-49F9406BD7D3Q57824783-ED7EDE03-0788-422D-8D39-3EF6C189673BQ58793145-F839FD16-C415-4E0C-B304-0DB6392BD39FQ58903530-C4AEB176-2680-43C8-831A-CBF7ACB358F2
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Primary hyperparathyroidism and the skeleton.
@en
Primary hyperparathyroidism and the skeleton.
@nl
type
label
Primary hyperparathyroidism and the skeleton.
@en
Primary hyperparathyroidism and the skeleton.
@nl
prefLabel
Primary hyperparathyroidism and the skeleton.
@en
Primary hyperparathyroidism and the skeleton.
@nl
P2860
P1476
Primary hyperparathyroidism and the skeleton.
@en
P2093
Leif Mosekilde
P2860
P356
10.1111/J.1365-2265.2007.03162.X
P577
2008-07-01T00:00:00Z